This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Centene Corporation is a well-diversified, multi-national healthcare company that primarily provides a set of services to the government sponsored healthcare programs. The company serves the under-insured and uninsured individuals through member-focused services. It is also engaged in providing education and outreach programs to inform and assist members in accessing quality, appropriate healthcare services. Centene is now a $100-billion plus enterprise catering healthcare services to more than 24 million members across 50 states. The recent acquisition of WellCare Health leveraged the company’s position as the largest Medicaid managed care organization in the country. The combined entity now has 22 million members. In 2019, the company retained its market-leading position nationwide, serving 1.8 million exchange members across 20 states at the year-end.
Why Centene (CNC) is Poised to Beat Earnings Estimates Again
by Zacks Equity Research
Centene (CNC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Buy These 5 Price-to-Book Value Stocks for Gains in 2024
by Kinjel Shah
The P/B ratio helps to identify low-priced stocks with high growth prospects. General Motors Company (GM), Park Hotels & Resorts (PK), Qifu Technology (QFIN), Centene (CNC) and Deutsche Bank Aktiengesellschaft (DB) are some such stocks.
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Should You Invest in the Invesco S&P 500 Equal Weight Health Care ETF (RSPH)?
by Zacks Equity Research
Sector ETF report for RSPH
Here's Why You Should Retain Centene (CNC) Stock For Now
by Zacks Equity Research
Centene (CNC) remains well-poised for growth on the back of overall membership growth, acquisitions, business streamlining efforts and a growing cash balance.
Reasons to Retain HCA Healthcare (HCA) Stock in Your Portfolio
by Zacks Equity Research
HCA Healthcare's (HCA) improving top line, acquisition initiatives and a robust growth outlook poise the company well for growth.
Why You Should Retain Cigna (CI) Stock in Your Portfolio
by Zacks Equity Research
Cigna's (CI) strong Evernorth and Cigna Healthcare segments, growing medical membership and a positive 2023 outlook poise it well for growth.
Why You Should Invest in Encompass Health (EHC) Stock for Now
by Zacks Equity Research
Encompass Health (EHC) is well-poised for growth on the back of growing revenues, an aging U.S. population, joint ventures and solid cash reserves.
Should SPDR Russell 1000 Low Volatility Focus ETF (ONEV) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for ONEV
UnitedHealth Group's (UNH) Brazil Unit Draws Buyout Interests
by Zacks Equity Research
UnitedHealth Group (UNH) expects to divest its troubled Brazil business, enhancing its overall results.
Zacks.com featured highlights Park Hotels & Resorts, Centene, Solo Brands and AZZ
by Zacks Equity Research
Park Hotels & Resorts, Centene, Solo Brands and AZZ have been highlighted in this Screen of The Week article.
4 Low Price-to-Cash Flow Stocks to Navigate the Market in 2024
by Sumit Singh
Value investing is essentially about selecting stocks that are usually cheap but fundamentally sound. Park Hotels & Resorts (PK), Centene (CNC), Solo Brands (DTC) and AZZ Inc. (AZZ) boast low P/CF ratios.
4 Low Price-to-Book Stocks to Buy in the New Year
by Kinjel Shah
The P/B ratio helps to identify low-priced stocks with high growth prospects. Solo Brands (DTC), Park Hotels & Resorts (PK), Centene (CNC) and Deluxe Corporation (DLX) are some such stocks.
Is SPDR Russell 1000 Low Volatility Focus ETF (ONEV) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for ONEV
The Zacks Analyst Blog Highlights UnitedHealth, Humana, Centene and Molina Healthcare
by Zacks Equity Research
UnitedHealth, Humana, Centene and Molina Healthcare are included in this Analyst Blog.
4 Health Insurers Likely to Maintain Winning Streak in 2024
by Debasmita Chatterjee
Medical-HMO stocks like UNH, HUM, CNC and MOH are expected to reap the benefits of an aging U.S. population and growing premiums in 2024. However, challenges related to the resumption of elective procedures might play spoilsport.
Here's Why Centene (CNC) is a Strong Value Stock
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Cigna's (CI) Medicare Advantage Unit Draws Acquisition Interest
by Zacks Equity Research
The final bids for Cigna's (CI) Medicare Advantage unit are expected next week.
Ensign Group (ENSG) Sanctions 4% Quarterly Dividend Hike
by Zacks Equity Research
Ensign Group (ENSG) announces a dividend hike, underlining a strong financial position and continued focus on deploying capital to shareholders.
Should Value Investors Buy Centene (CNC) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Centene (CNC) Ties Up to Aid Its Marketplace Members in Chicago
by Zacks Equity Research
Centene's (CNC) product - Ambetter of Illinois - along with RUSH aim to provide improved access to quality healthcare services for CNC's members in Chicago, and thereby grow its Marketplace business.
UnitedHealth Group's (UNH) Arm Launches OptumRx Weight Engage
by Zacks Equity Research
UnitedHealth Group (UNH) enhances Optum Rx's offerings with the launch of the Weight Engage program.
Zacks.com featured highlights include JAKKS Pacific, JinkoSolar Holding, Centene, ADT and Centerspace
by Zacks Equity Research
JAKKS Pacific, JinkoSolar Holding, Centene, ADT and Centerspace are part of the Zacks Screen of the Week article.
Centene (CNC) Unveils its 2024 Projections: Key Takeaways
by Zacks Equity Research
Centene's (CNC) board boosts its share buyback program with a new $4 billion fund.
Brookdale's (BKD) November 2023 Weighted Average Occupancy Up
by Zacks Equity Research
Brookdale (BKD) witnesses 25 straight months of year-over-year increase in weighted average occupancy level.